SHIFT BIOSCIENCE LIMITED

Active Cambridge

Research and experimental development on biotechnology

11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
S

SHIFT BIOSCIENCE LIMITED

Research and experimental development on biotechnology

Founded 30 May 2017 Active Cambridge, United Kingdom 11 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

NEXTNEURAL LIMITED 30 May 2017 — 4 Oct 2017
Accounts Submitted 9 Sept 2025 Next due 31 Mar 2027 11 months remaining
Confirmation
Net assets £9M £6M 2024 year on year
Total assets £9M £7M 2024 year on year
Total Liabilities £364K £220K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Salisbury House Station Road Cambridge CB1 2LA United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SHIFT BIOSCIENCE LIMITED (10793871), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 30 May 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£8.28M

Increased by £6.54M (+377%)

Net Assets

£8.74M

Increased by £6.45M (+283%)

Total Liabilities

£364.17k

Increased by £220.36k (+153%)

Turnover

N/A

Employees

11

Increased by 2 (+22%)

Debt Ratio

4%

Decreased by 2 (-33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 5

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Oct 2024Seed
Investor 2Oct 2024Seed
Investor 3Oct 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

14 Allotments 200,695 Shares £13.86m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 May 202510,800£0.108£0
11 Jun 2024102,460£8.59m£83.8
24 Aug 202211,509£949k£82.5
17 Feb 2022870£72k£82.5
4 Feb 202238,641£3.19m£82.5

Officers

Officers

2 active 1 resigned
Status
Brendan SwainDirectorBritishEngland3117 Jan 2022Active
Daniel Jeremy IvesDirectorBritishUnited Kingdom3930 May 2017Active

Shareholders

Shareholders (32)

Daniel Ives
27.9%
85,000
Bgf Investments Lp
14.5%
44,209

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Daniel Jeremy Ives

British

Active
Notified 30 May 2017
Residence United Kingdom
DOB September 1986
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors As Firm

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Apr 2026ResolutionResolutions
26 Mar 2026OfficersAppointment of Andrew Fraley as director on 2026-03-13
25 Sept 2025OfficersAppointment of Dr Laurence Edward Reid as director on 2025-08-01
18 Sept 2025OfficersAppointment of Lord David Prior as director on 2025-08-01
9 Sept 2025AccountsAnnual accounts made up to 2025-06-30
11 Apr 2026 Resolution

Resolutions

26 Mar 2026 Officers

Appointment of Andrew Fraley as director on 2026-03-13

25 Sept 2025 Officers

Appointment of Dr Laurence Edward Reid as director on 2025-08-01

18 Sept 2025 Officers

Appointment of Lord David Prior as director on 2025-08-01

9 Sept 2025 Accounts

Annual accounts made up to 2025-06-30

Recent Activity

Latest Activity

Resolutions

1 weeks ago on 11 Apr 2026

Appointment of Andrew Fraley as director on 2026-03-13

3 weeks ago on 26 Mar 2026

Appointment of Dr Laurence Edward Reid as director on 2025-08-01

6 months ago on 25 Sept 2025

Appointment of Lord David Prior as director on 2025-08-01

7 months ago on 18 Sept 2025

Annual accounts made up to 2025-06-30

7 months ago on 9 Sept 2025